Host genetic variants associated with susceptibility and severity of pneumococcal pneumonia in adult patients.

Autor: Boix-Palop L; Infectious Diseases Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain. lboix@mutuaterrassa.cat.; Universitat Internacional de Catalunya, Barcelona, Spain. lboix@mutuaterrassa.cat.; Universitat de Barcelona, Barcelona, Spain. lboix@mutuaterrassa.cat., Arranz MJ; Fundació Docència i Recerca Mútua Terrassa, Barcelona, Spain., Sangil A; Internal Medicine Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain., Dietl B; Infectious Diseases Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain., Xercavins M; Microbiology Department, CatLab, Barcelona, Spain., Pérez J; Microbiology Department, CatLab, Barcelona, Spain., Calbo E; Infectious Diseases Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain. ecalbo@mutuaterrassa.es.; Universitat Internacional de Catalunya, Barcelona, Spain. ecalbo@mutuaterrassa.es.
Jazyk: angličtina
Zdroj: Pneumonia (Nathan Qld.) [Pneumonia (Nathan)] 2023 Dec 25; Vol. 15 (1), pp. 18. Date of Electronic Publication: 2023 Dec 25.
DOI: 10.1186/s41479-023-00120-w
Abstrakt: Background: Pneumococcal community-acquired pneumonia (P-CAP) is a major cause of morbidity and hospitalization. Several host genetics factors influencing risk of pneumococcal disease have been identified, with less information about its association with P-CAP. The aim of the study was to assess the influence of single nucleotide polymorphisms (SNP) within key genes involved in the innate immune response on the susceptibility to P-CAP and to study whether these polymorphic variants were associated with the severity and outcome of the episodes in a cohort of adult Caucasian patients.
Methods: Seventeen SNPs from 7 genes (IL-R1, IL-4, IL-10, IL-12B, NFKBIA, NFKBIE, NFKBIZ) were analyzed. For susceptibility, a case-control study including a cohort of 57 adult with P-CAP, and 280 ethnically matched controls was performed. Genetic influence on clinical severity and outcome was evaluated in a prospective observational study including all consecutive adult P-CAP patients from November 2015 to May 2017.
Results: The NFKBIA polymorphism rs696 and a haplotype combination were associated with susceptibility to P-CAP (OR = 0.62, p = 0.005 and OR = 0.63, p = 0.008, respectively). The SNP IL4 rs2227284 was associated with severe P-CAP (OR = 2.17, p = 0.04). IL-R1 (rs3917267) and IL-10 (rs3024509) variants were related with respiratory failure (OR = 3.31, p = 0.001 and OR = 0.18, p = 0.003, respectively) as well as several haplotype combinations in NFKBIA, NFKBIZ, IL-R1 and IL-10 (p = 0,02, p = 0,01, p = 0,001, p = 0,03, respectively). CURB-65 values were associated with the IL-10 rs3024509 variant (beta = - 0.4, p = 0.04), and with haplotype combinations of NFKBIZ and IL-10 (p = 0.05, p = 0.04, respectively). Genetic variants in IL-10 (rs3024509) and in IL-12B (rs730691) were associated with PSI values (beta = - 0.54, p = 0.01, and beta = - 0.28, p = 0.04, respectively), as were allelic combinations in IL-R1 (p = 0.02) and IL-10 (p = 0.01). Finally, several polymorphisms in the IL-R1 gene (rs13020778, rs2160227, & rs3917267) were associated with the time elapsed until clinical stability (beta = - 0.83, p = 0.03; beta = - 1, p = 0.02 and beta = 1.07, p = 0.008, respectively).
Conclusions: A genetic variant in NFKBIA was associated with susceptibility to P-CAP in adult Caucasian patients and genetic variants from key cytokines of the innate immune response (Il-4, IL-10, IL-R1 and IL-12B) and NF-κB inhibitors were associated with different phenotypes of severe P-CAP. If validated, these SNPs may help to identify people at risk of P-CAP or severe P-CAP on which preventive measures could be applied.
(© 2023. The Author(s).)
Databáze: MEDLINE